BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32706857)

  • 1. Donor Cytomegalovirus Transmission Patterns in Solid Organ Transplant Recipients With Primary Infection.
    Hasing ME; Pang XL; Mabilangan C; Preiksaitis JK
    J Infect Dis; 2021 Mar; 223(5):827-837. PubMed ID: 32706857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants.
    Manuel O; Pang XL; Humar A; Kumar D; Doucette K; Preiksaitis JK
    J Infect Dis; 2009 Jun; 199(11):1621-8. PubMed ID: 19385736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-transmitted and community-acquired cytomegalovirus infection in seronegative solid organ transplant recipients receiving seronegative donor organs.
    Mabilangan C; Burton C; Nahirniak S; O'Brien S; Preiksaitis J
    Am J Transplant; 2020 Dec; 20(12):3509-3519. PubMed ID: 32428296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus transmission in mismatched solid organ transplant recipients: Are factors other than anti-viral prophylaxis at play?
    Hernandez C; Mabilangan C; Burton C; Doucette K; Preiksaitis J
    Am J Transplant; 2021 Dec; 21(12):3958-3970. PubMed ID: 34174153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risk associated with cytomegalovirus infection among solid organ transplant recipients in the United States.
    Geris JM; Spector LG; Pfeiffer RM; Limaye AP; Yu KJ; Engels EA
    Cancer; 2022 Nov; 128(22):3985-3994. PubMed ID: 36126024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor Graft Cytomegalovirus Serostatus and the Risk of Arterial and Venous Thrombotic Events in Seronegative Recipients After Non-Thoracic Solid Organ Transplantation.
    Belga S; MacDonald C; Chiang D; Kabbani D; Shojai S; Abraldes JG; Cervera C
    Clin Infect Dis; 2021 Mar; 72(5):845-852. PubMed ID: 32025704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Bruminhent J; Rotjanapan P; Watcharananan SP
    Transplant Proc; 2017 Jun; 49(5):1048-1052. PubMed ID: 28583524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing Proportion of High-risk Cytomegalovirus Donor-positive/Recipient-negative Serostatus in Solid Organ Transplant Recipients.
    Imlay H; Wagener MM; Vutien P; Perkins J; Singh N; Limaye AP
    Transplantation; 2023 Apr; 107(4):988-993. PubMed ID: 36173456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of glycoproteins B and H genotypes to predict the development of Cytomegalovirus disease in solid organ transplant recipients.
    Barrado L; Prieto C; Hernando S; Folgueira L
    J Clin Virol; 2018 Dec; 109():50-56. PubMed ID: 30500488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.
    Young PG; Rubin J; Angarone M; Flaherty J; Penugonda S; Stosor V; Ison MG
    Transpl Infect Dis; 2016 Jun; 18(3):390-5. PubMed ID: 27037651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMV infection and management among pediatric solid organ transplant recipients.
    Downes KJ; Sharova A; Boge CLK; Vader D; Mitrou M; Hayes M; Galetaki DM; Gianchetti L; Vella LA; Li Y
    Pediatr Transplant; 2022 May; 26(3):e14220. PubMed ID: 34994041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients.
    Fisher CE; Alexander J; Bhattacharya R; Rakita RM; Kirby KA; Boeckh M; Limaye AP
    Transpl Infect Dis; 2016 Jun; 18(3):372-80. PubMed ID: 27004439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk-stratified approach to cytomegalovirus prevention in pediatric solid organ transplant recipients.
    Suresh S; Lee BE; Robinson JL; Akinwumi MS; Preiksaitis JK
    Pediatr Transplant; 2016 Nov; 20(7):970-980. PubMed ID: 27565955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coinfection rates and clinical outcome data for cytomegalovirus and Epstein-Barr virus in post-transplant patients: A systematic review of the literature.
    Anderson-Smits C; Baker ER; Hirji I
    Transpl Infect Dis; 2020 Dec; 22(6):e13396. PubMed ID: 32603496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in the management of cytomegalovirus infection after solid organ transplantation.
    Eid AJ; Razonable RR
    Drugs; 2010 May; 70(8):965-81. PubMed ID: 20481654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Going beyond serology for stratifying the risk of CMV infection in transplant recipients.
    Navarro D; Fernández-Ruiz M; Aguado JM; Sandonís V; Pérez-Romero P
    Rev Med Virol; 2019 Jan; 29(1):e2017. PubMed ID: 30358016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in Solid Organ Transplant Recipients.
    Fisher CE; Knudsen JL; Lease ED; Jerome KR; Rakita RM; Boeckh M; Limaye AP
    Clin Infect Dis; 2017 Jul; 65(1):57-63. PubMed ID: 28369203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
    Manuel O; Asberg A; Pang X; Rollag H; Emery VC; Preiksaitis JK; Kumar D; Pescovitz MD; Bignamini AA; Hartmann A; Jardine AG; Humar A
    Clin Infect Dis; 2009 Oct; 49(8):1160-6. PubMed ID: 19751151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of recipient age on mortality among Cytomegalovirus (CMV)-seronegative lung transplant recipients with CMV-seropositive donors.
    Belga S; Hussain S; Avery RK; Nauroz Z; Durand CM; King EA; Massie A; Segev DL; Connor AE; Bush EL; Levy RD; Shah P; Werbel WA
    J Heart Lung Transplant; 2024 Apr; 43(4):615-625. PubMed ID: 38061469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.